How rooting around in the dirt landed an East Bay startup an $80M deal
It is the second drug-target deal disclosed by the four-year-old UC Berkeley spinout in the past five months. |!| Berkeley San Francisco
It is the second drug-target deal disclosed by the four-year-old UC Berkeley spinout in the past five months. |!| Berkeley San Francisco